Abstract-Effects of several autonomic agents on the cytotoxicity of mitomycin C in HeLa cells were studied.
A number of recent studies have pointed to an important role of cyclic adenosine 3',5' monophosphate (cyclic AMP) in the regu lation of cell growth (1) and the differen tiation (2, 3) . Some transformed mammalian cells possess lower cyclic AMP levels than the corresponding normal cells when the cells were not stimulated by any agents (1, 4) . It was shown that the addition of cyclic AMP or its analogues decreased the prolifer ation of transformed cells and caused a reversion (5) , and administration of cyclic AMP or agents which elevated the intra cellular cyclic AMP level inhibited the tumor cell growth in vitro and in vivo (6-9). Furthermore, Tisdale and Phillips (10) showed that the nitrogen mustard type alkylating agents such as chlorambucil and merpharan caused an elevation of the intracellular cyclic AMP level in Walker carcinoma cells at doses which killed the cells. Kotani et al. (11) reported that Vinca alkaloids not only in creased cyclic AMP in lymphoma cells by itself, but also enhanced the same action of some biogenic amines or prostaglandin El.
Although it has been suggested that the antitumor effect may be enhanced by the elevation of the cyclic AMP level in tumor cells, there have been few reports on the practical application for antitumor treatment of the combination of antitumor agents with neurotransmitters or biogenic amines except xanthine derivatives. We previously reported that reserpine, central nervous system depressant which was reported to inhibit the activity of cyclic nucleotide phosphodiesterase (12) , poten tiated the antitumor effect of some antitumot agents on rat ascites hepatomas (13) and mouse leukemia L1210 (14) . The preseni work shows that 8-adrenergic stimulants among several autonomic agents synergis tically enhance the cytotoxicity of mitomycin C, and this effect may be related to the elevation of intracellular cyclic AMP caused by these agents.
MATERIALS AND METHODS
Reagents: The antitumor agent used was mitomycin C which was purchased from Sankyo Co., Tokyo. Other chemicals obtained from commercial sources were dl-norepin ephrine (Sankyo Co.), I-phenylephrine hydro chloride and phenoxybenzamine hydro chloride (Tokyo Kasel Kogyo Co., Tokyo), epinephrine and acetylcholine chloride (Dai ichi Seiyaku Co., Tokyo), dI-isoproterenol hydrochloride (Nakarai Chemicals Ind., Kyo to), phentolamine mesylate (Ciba Geigy Japan Ltd., Osaka), atropine sulfate (E. Merck Japan Ltd., Tokyo), adrenochrome and dibutyryl cyclic AMP (Sigma Chemical Co., St. Louis, U.S.A.), and nicotine tartrate (Wako Pure Chemical Ind., Osaka). Ter butaline, turobuterol and propranolol were kindly provided by the Hokuriku Seiyaku Co., Katsuyama. These agents were dissolved in Eagle's minimum essential medium (MEM, pH 7.4) immediately before use.
Cell culture and treatments: HeLa S3 cells were used in this study. They had a doubling time of about 24 hr under the standard culture conditions. The cells were routinely cultured in Eagle's MEM supplemented with 5% calf serum (maintenance medium) in gum-stoppered square bottles at 37 °C. The cells were removed from the bottles with 0.02% ethylenediamine tetraacetic acid disodium salt and 0.02% pronase for sub culture.
The colony-forming ability was determined by placing aliquots of 1 X104 cells in 35-mm plastic petri dishes. The dishes were incubated at 37 °C in a humidified 5% C02 incubator. After 24 hr, the cells plated with about 50% plating efficiency were pretreated with graded concentrations of each autonomic agent for different times and then exposed to various concentrations of mitomycin C for 2 hr. The treated cells were washed with Hanks' solution and cultured in the maintenance medium in a C02 incubator for 3-4 days. The colonies formed with 8-10 cells were fixed, stained with Crystal Violet, and counted microscopically. The term of "synergism" or "synergistical enhancement" is used in this study according to the definition that a combination of a non-cytotoxic concen tration of an autonomic agent with mitomycin C provides a statistically significant inhibition of the colony-forming ability over 20% more than the inhibitory effect of mitomycin C alone.
Determination of intracellular cyclic AMP contents: Isoproterenol and mitomycin C were added to confluent monolayers of HeLa cells (about 2.5X106 cells/50-mm petri dish) according to the above mentioned treatment schedules. After the treatment, the dishes were cooled immediately; and the cells were washed, harvested by scraping with a rubber policeman, suspended in 1 ml of phosphate-buffered saline, and used for the determination of cyclic AMP. The intra cellular cyclic AMP was determined using a radioimmunoassay kit from the Yamasa Shoyu Co., Choshi, following the procedure de veloped by Honma et al. (15 Cells were treated with 10-14-10-4 M of each agent 1 hr prior to an additional exposure of 0.1 ,ug/ml of mitomycin C for 2 hr. The evalua tion of synergism (+) follows the definition given in "Materials and Methods."
showed a synergism on the inhibition of colony-forming ability of the cells in combi nation with mitomycin C; but all of the a adrenergic agonists and a or (3-antagonists did not have such an effect. Acetylcholine, nicotine and atropine did not affect the cytotoxicity of mitomycin C. In addition, adrenochrome, which is spontaneously pro duced as an oxidative product from epin ephrine even in a slightly alkaline solution such as the culture medium used in this study, did not influence the effect of mitomycin C. Therefore, the following experiments were carried out with the use of isoproterenol which is known to be the most potent (3 adrenergic stimulant.
Combined effect of isoproterenol with mitomycin C.: When isoproterenol was added to the cells in the concentration range of 10-6-10-14 M and at 15-60 min before the addition of mitomycin C, the effect of mitomycin C was significantly enhanced. Higher concentrations of isoproterenol or longer times of treatment with this agent were rather less effective (Fig. 1) . Figure 2 shows the result of a combined experiment using the optimal pretreatment condition with isoproterenol 'on the effect of mitomycin C. The cytotoxic effects of various concen this agent markedly potentiated the effect of mitomycin C (Fig. 4) .
Combined effect of isoproterenol with mitomycin C on the intracellular cyclic AMP in HeLa cells: As shown in Fig. 5A, 10 agent at 10-8 M, reached the maximal level by 30 min, and then moderately decreased (Fig.  5B) . The result obtained in combined treat ment with isoproterenol and mitomycin C is indicated in Fig. 6 . When 0.1 ,ug/ml of mitomycin C was added to the cells at 30 min after the addition of 10-8 M isoproterenol, a time at which the intracellular cyclic AMP level reached the maximal level, the high level of cyclic AMP in the cells was main tained for a significantly long period of time even if these agents were washed out; while mitomycin C alone only slightly increased the intracellular cyclic AMP.
DISCUSSION
It was reported that several tumor cells including HeLa cells contained (3-adreno ceptors and adenylate cyclase in their mem branes and produced cyclic AMP after incubation with 3-stimulants (16) (17) (18) .
In this study, we observed that the colony forming ability of HeLa cells treated with the antitumor agent mitomycin C was significantly decreased by pretreatment with 3-adrenergic stimulants at very low and non-cytotoxic concentrations. Such concentrations of these agents were considered to be physiological and present in tissues and blood. This syn ergistic effect of the t3-stimulants was cancelled by propranolol. However, none of the other autonomic agents showed such a combined effect with mitomycin C. Iso proterenol, one of the 8-stimulants, elicited a rapid rise in cellular cyclic AMP; and the time of the maximal elevation of intracellular cyclic AMP by this agent agreed with the optimal pretreatment time of this agent in the combined cytotoxicity with mitomycin C (Figs. 1 and 5 ). There was, however, in sufficient correspondence in the concen tration. The optimal combined cytotoxic effect of isoproterenol was shown in the range of 10-8-10-11) M, but the significant increase of cyclic AMP in the cells was produced by about two orders of magnitude higher concentrations of this agent. This seems to be attributable to the difference in the cell density at the point of time of addition of isoproterenol between about 5 x 103 cells/ dish of 35-mm diameter in the assay of colony-forming ability and about 2.5x106 cells/dish of 50-mm diameter in the cyclic AMP assay (see Materials and Methods). This study further showed that the high level of intracellular cyclic AMP induced by isoproterenol was kept up a long time by the combination with mitomycin C. However, because mitomycin C increased cyclic AMP in the cells only slightly by itself, it is difficult to separate this finding from the additive effect of these agents on the intracellular cyclic AMP level. As to the effect of antitumor agents on the intracellular cyclic AMP level, there is little evidence. Tisdale and Phillips (10) reported that the possible mechanism of the elevation of intracellular cyclic AMP by chlorambucil and merpharan may be the inhibition of a cyclic nucleotide phos phodiesterase with a low Km value. It had been suggested that the receptors for Vinca alkaloids were distinct from those for biogenic amines and prostaglandin E, when these alkaloids additively increased the intra cellular cyclic AMP in lymphoma cells in combination with these biogenic compounds (11) , and other authors reported that these alkaloids blocked the increase in cyclic nucleotide phosphodiesterase activity (19, 20) . On the other hand, the effect of mito mycin C on the system of cyclic AMP biosynthesis is not yet fully understood. Some recent papers have shown that elevated cyclic AMP levels in cells induced the cells arrested at Go/G, of the cell phase to initiate DNA synthesis (3, 21, 22) .
Therefore, it may be suggested that the cyclic AMP elevated via the stimulation of f-adrenoceptors by Q-adrenergic stimulants and mitomycin C synergistically affected the progression about the cell cycle. This sug gestion may be supported by the finding that dibutyryl cyclic AMP also potentiated the effect of mitomycin C (Fig. 4) . However, because there is little evidence to define the mechanism for (3-adrenergic stimulants to enhance the effect of mitomycin C, further experiments are required to understand the role of the intracellular cyclic AMP elevated by these agents and the point of action of mitomycin C in the continuance of the elevation of cyclic AMP content in the cells. Whether (3-adrenergic stimulants can be applied to antitumor chemotherapy and whether other biogenic amines which in crease the intracellular cyclic AMP level possess the potency to enhance the effect of antitumor agents are also currently under investigation.
